Furthermore, NPs are able to counteract both the constitutive and EVs-induced NLRP3 activation in cancerous and non-cancerous prostate cells (62), supporting the critical role of these molecules in prostate cancer (87). Here, NLRP3 is linked to prostate carcinoma.